Table 1.
The relationships of demographic features and comparison of serum parathormone levels with fibroblast growth factor-23, calcium, and phosphorus in the dialysis patients.
| PTH < 300 pg/mL | PTH > 300 pg/mL | P | |
|---|---|---|---|
| Age; mean ± SD | 47,94 ± 14,21 | 46,88 ± 16,57 | 0,394 |
| Gender; n (%) | |||
| Male | 17 (51,50) | 24 (42,90) | 0,506 |
| Female | 16 (48,50) | 32 (57,10) | |
| Dialysis duration (years); mean ± SD | 3,03 ± 1,91 | 4,71 ± 3,03 | 0,587 |
| Etiology; n (%) | |||
| Hypertension | 14 (42,40) | 25 (44,70) | 0,923 |
| Postrenal KBH | 7 (21,30) | 7 (12,50) | |
| Glomerulonephritis | 12 (36,40) | 23 (41,10) | |
| Unknown | — | 1 (1,80) | |
| FGF-23Log 10 (ng/mL); mean ± SD | 159,40 ± 3,66 | 741,31 ± 4,77 | 0,001 ∗∗ |
| Calcium (mg/dL); mean ± SD | 8,61 ± 0,99 | 8,58 ± 0,93 | 0,871 |
| Phosphorus (mg/dL); mean ± SD | 4,38 ± 1,07 | 5,62 ± 1,54 | 0,0001 |
| Ca∗P (mg2/dL2) mean ± SD | 37,77 ± 10,61 | 48,46 ± 14,75 | 0,001 |
Data are presented as n(%). PTH: parathormone; KBH: chronic renal diseases; FGF-23 Log 10: fibroblast growth factor; Ca: calcium; P: phosphorus.
**Statistical significance positive correlation (P < 0,01).